Stimulation of B cells in the IL-21/CD40L system in healthy donors and in patients with common variable immunodeficiency

Abstract

Introduction. Common variable immunodeficiency (CVID) refers to primary immunodeficiencies. To date, a number of genes have been identified, mutations in which lead to the development of CVID. However, monogenic defects underlie no more than 10 % of CVID cases, and the bulk of CVID is associated with the participation of many genes. Under these conditions, to search for and decipher possible pathogenetic factors, it is effective to use the analysis of functional defects in the activation of B-lymphocytes.

The aim of the study - to search for functional defects in the activation of B-lymphocytes in patients with CVID when stimulated in vitro in the IL-21/CD40L system.

Material and methods. The study involved 14 patients with CVID. The group of comparison consisted of 10 healthy volunteers. Samples of blood mononuclear cells were obtained from peripheral blood and used to activate T cells. Phytohemagglutinin (PHA) or a combination of phorbol myristate acetate (PMA) and ionomycin (Io) were used as activators. CD40L induction on CD4+-cells was assessed using flow cytometry. B cells were isolated from the mononuclear cells by the method of immunomagnetic separation and B cell activation in the IL-21/CD40L system was carried out. Recombinant IL-21 and A549 feeder cells stably transfected with the CD40L gene were used as activating stimuli. The differentiation of B cells into plasmablasts was determined by the proportion of cells with the CD19+CD27+CD38+CD20low phenotype. Subpopulations of naive (IgM+IgD+), unswitched (IgM+CD27+) and switched (IgG+CD27+) B cells were isolated using a flow sorter. The secretion of IgG and IgM was determined using an enzyme immunoassay, and the number of IgG-secreting cells was estimated using the ELISpot method (Enzyme-Linked ImmunoSpot Analysis).

Results. When T cells were activated by polyclonal stimulants, some of the CD4+-cells began to express CD40L. In T cells of healthy volunteers, stimulation with PHA or a combination of PMA and Io resulted in CD40L expression on 10 and 80 % of CD4+-cells, respectively. T cells from patients with CVID showed comparable activation and the proportion of CD4+CD40L+-cells was close to normal. When stimulated in the IL-21/CD40L system, B cells of patients with CVID retained the ability to differentiate into plasmablasts with the CD19+CD27+CD38+CD20low phenotype, but secreted IgG 10 times less than B cells from healthy volunteers.

Сonclusion. In CVID patients the B cell activation pathways associated with IL-21 and CD40L remain intact, and the functional defects observed in CVID are obviously associated with other molecules.

Keywords:common variable immunodeficiency; B lymphocytes; plasmablasts; IL-21; CD40L

For citation: Astakhova E.A., Frolov E.A., Shilkina A.B., Byazrova M.G., Latysheva E.A., Latysheva T.V., Filatov A.V Stimulation of B cells in the IL-21/CD40L system in healthy donors and in patients with common variable immunodeficiency. Immunologiya. 2021; 41 (6): 631-40. DOI: https://doi.org/10.33029/0206-4952-2021-42-6-631-640 (in Russian)

Funding. The study was supported by the grant of Russian Foundation for Basic Research (RFBR) No. 20-015-00318. Byazrova M.G. was supported by the Strategic Academic Leadership Program from RUDN University of the MSHE of Russia.

Conflict of interests. The authors declare no conflict of interests.

References

1. Jolles S. The variable in common variable immunodeficiency: a disease of complex phenotypes. J. Allergy Clin. Immunol. Pract 2013; 1: 545–56; quiz 557. DOI: https://doi.org/10.1016/j.jaip.2013.09.015

2. Maglione P.J., Ko H.M., Beasley M.B., Strauchen J.A., Cunningham-Rundles C. Tertiary lymphoid neogenesis is a component of pulmonary lymphoid hyperplasia in patients with common variable immunodeficiency. J. Allergy Clin. Immunol 2014; 133: 535–42. DOI: https://doi.org/10.1016/j.jaci.2013.08.022

3. Lushova A.A., Zheremyan E.A., Astakhova E.A., Spiridonova A.B., Byazrova M.G., Filatov A.V. B-lymphocyte subsets: functions and molecular markers. Immunologiya. 2019; 40 (6): 63–76. DOI: https://doi.org/10.24411/0206-4952-2019-16009 (in Russian)

4. Piqueras B., Lavenu-Bombled C., Galicier L., Bergeson-van der Cruyssen F., Mouthon L., Chevret S., et al. Common variable immunodeficiency patient classification based on impaired B cell memory differentiation correlates with clinical aspects. J. Clin. Immunol. 2003; 23: 385–400. DOI: https://doi.org/10.1023/A:1025373601374

5. Warnatz K., Denz A., Dräger R., Braun M., Groth C., Wolff-Vorbeck G., et al. Severe deficiency of switched memory B cells (CD27+IgM−IgD−) in subgroups of patients with common variable immunodeficiency: a new approach to classify a heterogeneous disease. Blood. 2002; 99: 1544–51. DOI: https://doi.org/10.1182/blood.V99.5.1544

6. Wehr C., Kivioja T., Schmitt C., Ferry B., Witte T., Eren E., et al. The EUROclass trial: defining subgroups in common variable immunodeficiency. Blood 2008; 111: 77–85. DOI: https://doi.org/10.1182/blood-2007-06-091744

7. Bogaert D.J.A., Dullaers M., Lambrecht B.N., Vermaelen K.Y., De Baere E., Haerynck F. Genes associated with common variable immunodeficiency: one diagnosis to rule them all? J. Med. Genet 2016; 53: 575–90. DOI: https://doi.org/10.1136/jmedgenet-2015-103690

8. Ettinger R., Sims G.P., Fairhurst A.-M., Robbins R., da Silva Y.S., Spolski R., et al. IL-21 induces differentiation of human naive and memory B cells into antibody-secreting plasma cells. J. Immunol. 2005; 175: 7867–79. DOI: https://doi.org/10.4049/jimmunol.175.12.7867

9. Avery D.T., Kalled S.L., Ellyard J.I., Ambrose C., Bixler S.A., Thien M., et al. BAFF selectively enhances the survival of plasmablasts generated from human memory B cells. J. Clin. Invest. 2003; 112: 286–97. DOI: https://doi.org/10.1172/JCI18025

10. Barbosa R.R., Silva S.L., Silva S.P., Melo A.C., Pereira-Santos M.C., Barata J.T., et al. Reduced BAFF-R and increased TACI expression in common variable immunodeficiency. J. Clin. Immunol. 2014; 34: 573–83. DOI: https://doi.org/10.1007/s10875-014-0047-y

11. Matsuda Y., Haneda M., Kadomatsu K., Kobayashi T. A proliferation-inducing ligand sustains the proliferation of human naïve (CD27−) B cells and mediates their differentiation into long-lived plasma cells in vitro via transmembrane activator and calcium modulator and cyclophilin ligand interactor and B-cell mature antigen. Cell. Immunol. 2015; 295: 127–36. DOI: https://doi.org/10.1016/j.cellimm.2015.02.011

12. Byazrova M.G., Astakhova E.A., Spiridonova A.B., Vasil’eva Yu.V., Prilipov A.G., Filatov A.V. IL-21/CD40L stimulation of human B-lymphocytes in vitro and their characteristics. Immunologiya. 2020; 41 (6): 18–27. DOI: https://doi.org/10.33029/0206-4952-2020-41-6-18-27 (in Russian)

13. Filatov A.V., Krotov G.I., Zgoda V.G., Volkov Y. Fluorescent immunoprecipitation analysis of cell surface proteins: A methodology compatible with mass-spectrometry. J. Immunol. Methods. 2007; 319: 21–33. DOI: https://doi.org/10.1016/j.jim.2006.09.014

14. Khvastunova A.N., Kuznetsova S.A., Al-Radi L.S., Vylegzhanina A.V., Zakirova A.O., Fedyanina O.S., et al. Anti-CD antibody microarray for human leukocyte morphology examination allows analyzing rare cell populations and suggesting preliminary diagnosis in leukemia. Sci. Rep. 2015; 5: 12573. DOI: https://doi.org/10.1038/srep12573

15. Berg E.A., Fishman J.B. Labeling antibodies with Cy5-Phycoerythrin. Cold Spring Harb. Protoc. 2019; 2019: pdb.prot099317. DOI: https://doi.org/10.1101/pdb.prot099317

16. Vira S., Mekhedov E., Humphrey G., Blank P.S. Fluorescent-labeled antibodies: Balancing functionality and degree of labeling. Anal. Biochem 2010; 402: 146–50. DOI: https://doi.org/10.1016/j.ab.2010.03.036

17. Foy T.M., Aruffo A., Bajorath J., Buhlmann J.E., Noelle R.J. Immune regulation by CD40 and its ligand GP39. Annu. Rev. Immunol 1996; 14: 591–617. DOI: https://doi.org/10.1146/annurev.immunol.14.1.591

18. van Kooten C., Banchereau J. CD40-CD40 ligand. J. Leukoc. Biol. 2000; 67: 2–17. DOI: https://doi.org/10.1002/jlb.67.1.2

19. Revy P., Geissmann F., Debré M., Fischer A., Durandy A. Normal CD40-mediated activation of monocytes and dendritic cells from patients with hyper-IgM syndrome due to a CD40 pathway defect in B cells. Eur. J. Immunol 1998; 28: 3648–54. DOI: https://doi.org/10.1002/(SICI)1521-4141(199811)28:11<3648::AID-IMMU3648>3.0.CO;2-U

20. Kowalczyk D., Macura-Biegun A., Zembala M. The expression of CD40 on monocytes of children with primary humoral immunodeficiencies. Pediatr. Res. 2006; 59: 816–9. DOI: https://doi.org/10.1203/01.pdr.0000219298.96471.18

21. Brugnoni D., Airò P., Lebovitz M., Malacarne F., Ugazio A.G., Notarangelo L.D., et al. CD4+ cells from patients with Common Variable Immunodeficiency have a reduced ability of CD40 ligand membrane expression after in vitro stimulation. Pediatr. Allergy Immunol 1996; 7: 176–9. DOI: https://doi.org/10.1111/j.1399-3038.1996.tb00129.x

22. Laberko A.L., Starichkova Yu.V., Khismatullina R.D., Persiantseva M.I., Maschan M.A., Balashov D.N., Rumyantsev A.G. Optimization of hematopoietic stem cell transplantation planning using medical information system in children with primary immunodeficiencies. Immunologiya. 2021; 42 (1): 49–59. DOI: https://doi.org/10.33029/0206-4952-2021-42-1-49-59 (in Russian)

23. Borte S., Pan-Hammarström Q., Liu C., Sack U., Borte M., Wagner U., et al. Interleukin-21 restores immunoglobulin production ex vivo in patients with common variable immunodeficiency and selective IgA deficiency. Blood. 2009; 114: 4089–98. DOI: https://doi.org/10.1182/blood-2009-02-207423

All articles in our journal are distributed under the Creative Commons Attribution 4.0 International License (CC BY 4.0 license)


JOURNALS of «GEOTAR-Media»